# Foreign drug import is now legal: SCOTUS decision **URL:** https://forum.fudiabetes.org/t/foreign-drug-import-is-now-legal-scotus-decision/1112 **Category:** Insurance **Created:** [June 1, 2017, 8:04am UTC](https://forum.fudiabetes.org/t/foreign-drug-import-is-now-legal-scotus-decision/1112 "2017-06-01T08:04:58Z") **Posts on this page:** 1 **Showing post:** 4
### Author: ![Michel](https://yyz2.discourse-cdn.com/flex030/user_avatar/forum.fudiabetes.org/michel/32/387_2.png) [@Michel](https://forum.fudiabetes.org/u/Michel) #### Post date: [June 1, 2017, 8:06am UTC](https://forum.fudiabetes.org/t/foreign-drug-import-is-now-legal-scotus-decision/1112/4 "2017-06-01T08:06:25Z")
**References** - [Blomberg announcement of the decision](https://www.bloomberg.com/news/articles/2017-05-30/u-s-supreme-court-curbs-patent-holders-power-to-block-resale): first report - [SCOTUS decision (PDF)](https://www.supremecourt.gov/opinions/16pdf/15-1189_ebfj.pdf). - [Daniel Hemel and Lisa Ouellette’s deep pre-ruling analysis of the consequences of possible decisions on the international drug market in the Columbia Law Review](http://columbialawreview.org/content/trade-and-tradeoffs-the-case-of-international-patent-exhaustion/). - [Amicus Brief by Frederick Abbott supporting the SCOTUS decision](https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2906967), specifically mentioning the import of pharmaceutical products as a purpose: Frederick Abbott is Edward Ball Eminent Scholar and Professor of International Law at Florida State University College of Law. - [Post-decision analysis by Frederick Abbott on consequences on parallel imports of drugs](https://www.ip-watch.org/2017/05/31/us-supreme-court-adopts-international-exhaustion-patents-paving-way-parallel-imports-exert-downward-pressure-domestic-pharmaceutical-prices/): “Further US legislation may not be required before parallel importers begin bringing patented medicines into the United States if such medicines are produced in FDA-inspected and approved facilities abroad, the medicines have been approved for sale in the United States and chain of custody records are satisfactory.” - [Interview with Professor Abbott on FUDiabetes](https://forum.fudiabetes.org/t/consequences-of-scotus-lexmark-decision-on-parallel-drug-imports-exclusive-interview-with-professor-abbott/1116) discussing specific consequences of decision on insulin imports into the US - Blomberg BNA (for pay outlet) has an outstanding analysis of likely consequences of the ruling, including for drug manufacturers and the re-import of drugs into the US - [Thomas Cotter’s Analysis of the ruling](http://comparativepatentremedies.blogspot.com/2017/05/observations-on-impression-products-v.html): he is Briggs and Morgan Professor at the University of Minnesota Law School, and had filed an amicus brief requesting that SCOTUS affirm the Federal Circuit decision. - [Daniel Hemel and Lisa Ouellette’s first thoughts on how the ruling may be skirted](https://writtendescription.blogspot.com/2017/05/licensing-in-shadow-of-impression.html): these suggestions are for tech companies and would not apply to pharma products. - [IPWatchDog’s analysis of the grounds of the reversal by SCOTUS](http://www.ipwatchdog.com/2017/05/30/supreme-court-lexmark-sales-exhausted-patent-rights/id=83824/): reviews the exact reasoning for the decision, but does not discuss consequences on drug market - [WorldIPReview Analysis of decision](http://www.worldipreview.com/news/impression-v-lexmark-scotus-curbs-patent-owner-powers-after-sale-14134): review of the case history, no discussion of drug implications - [SCOTUSblog analysis](http://www.scotusblog.com/2017/05/opinion-analysis-federal-circuit-loses-justices-categorically-reject-enforcement-post-sale-patent-restrictions/) – in-depth for patent issues, but not coverage of medicinal drugs - [First NYT analysis](https://www.nytimes.com/2017/05/30/business/supreme-court-patent-rights-lexmark.html): misses drug import implication - [Brian Fung’s review at the Washington Post](https://www.washingtonpost.com/news/the-switch/wp/2017/05/31/how-a-supreme-court-ruling-on-printer-cartridges-changes-what-it-means-to-buy-almost-anything/) – deep on patent but again missing medicinal drug issue - [First Fortune analysis](http://fortune.com/2017/05/30/supreme-court-printers/): misses drug import implication - [First Reuters report](https://www.usnews.com/news/us/articles/2017-05-30/us-top-court-restricts-patent-owners-right-to-block-resale-of-goods): no discussion of drug import - [The Hill analysis](http://thehill.com/policy/technology/335633-supreme-court-rules-in-favor-of-resellers-in-patent-case): also misses drug impact - [First Washington post report](https://www.washingtonpost.com/business/economy/supreme-court-restricts-some-rights-of-patent-owners/2017/05/30/fabef976-4539-11e7-98cd-af64b4fe2dfc_story.html): it’s a Blomberg cut-and-paste, no analysis - [Gizmodo analysis](http://gizmodo.com/fans-of-cheap-drugs-and-printer-ink-just-won-big-in-the-1795662756): the ONLY outlet that picked up on the drug angle! _Thanks to Rachel Sachs (@RESachs on Twitter), Associate Professor of Law at Washington University in St Louis, for tweeting about it:_ [https://twitter.com/RESachs/status/869564400063176704](https://twitter.com/RESachs/status/869564400063176704) _ **The discussion thread for this post is** [here](https://forum.fudiabetes.org/t/foreign-drug-import-is-now-legal-discussion-thread/1093/)._ _This article will continue to be updated throughout the day, as news develop._ _Last update: 6/1/2017 at 1:10 AM PST_ --- _[View the full topic](https://forum.fudiabetes.org/t/foreign-drug-import-is-now-legal-scotus-decision/1112)._